These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35311709)

  • 1. Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease.
    de Oliveira FF; Bertolucci PHF; Chen ES; Smith MC
    J Alzheimers Dis; 2022; 87(1):359-372. PubMed ID: 35311709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected LDLR and APOE Polymorphisms Affect Cognitive and Functional Response to Lipophilic Statins in Alzheimer's Disease.
    de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
    J Mol Neurosci; 2020 Oct; 70(10):1574-1588. PubMed ID: 32474901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.
    de Oliveira FF; Berretta JM; de Almeida Junior GV; de Almeida SS; Chen ES; Smith MC; Bertolucci PHF
    Indian J Med Res; 2019 Sep; 150(3):261-271. PubMed ID: 31719297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between CETP genetic polymorphisms and Alzheimer's disease risk: a meta-analysis.
    Chen JJ; Li YM; Zou WY; Fu JL
    DNA Cell Biol; 2014 Nov; 33(11):807-15. PubMed ID: 25105518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia.
    de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
    Neurosci Lett; 2017 Apr; 646():36-42. PubMed ID: 28274859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.
    de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
    Curr Alzheimer Res; 2018 Feb; 15(4):386-398. PubMed ID: 29034839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients.
    Sabbagh M; Malek-Ahmadi M; Levenson I; Sparks DL
    J Alzheimers Dis; 2013; 33(1):111-6. PubMed ID: 22914592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of angiotensin modulators according to
    Oliveira FF; Almeida SS; Chen ES; Smith MC; Bertolucci PHF
    Acta Neuropsychiatr; 2023 Dec; 35(6):346-361. PubMed ID: 37605989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of cerebrovascular metabolism genotypes with neuropsychiatric symptoms and age at onset of Alzheimer's disease dementia.
    Oliveira FF; Chen ES; Smith MC; Bertolucci PH
    Braz J Psychiatry; 2017; 39(2):95-103. PubMed ID: 28099631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia?
    Crum J; Wilson J; Sabbagh M
    Alzheimers Res Ther; 2018 Oct; 10(1):104. PubMed ID: 30285877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.
    Haag MD; Hofman A; Koudstaal PJ; Stricker BH; Breteler MM
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):13-7. PubMed ID: 18931004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.
    Geifman N; Brinton RD; Kennedy RE; Schneider LS; Butte AJ
    Alzheimers Res Ther; 2017 Feb; 9(1):10. PubMed ID: 28212683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.
    Wroolie T; Roat-Shumway S; Watson K; Reiman E; Rasgon N
    J Alzheimers Dis; 2020; 75(3):903-910. PubMed ID: 32390619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins for the treatment of dementia.
    McGuinness B; O'Hare J; Craig D; Bullock R; Malouf R; Passmore P
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007514. PubMed ID: 20687089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study.
    Padala KP; Padala PR; McNeilly DP; Geske JA; Sullivan DH; Potter JF
    Am J Geriatr Pharmacother; 2012 Oct; 10(5):296-302. PubMed ID: 22921881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription of lipophilic statins to Alzheimer's disease patients: some controversies to consider.
    Biondi E
    Neurol Sci; 2011 Apr; 32(2):195-201. PubMed ID: 20957505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statins.
    Algotsson A; Winblad B
    Dement Geriatr Cogn Disord; 2004; 17(3):109-16. PubMed ID: 14739530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease.
    Zhou X; Wu X; Wang R; Han L; Li H; Zhao W
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials.
    Winblad B; Jelic V; Kershaw P; Amatniek J
    Drugs Aging; 2007; 24(1):57-61. PubMed ID: 17233547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.